Legal clarity allows the use of GnRH analogues in research
BMJ
.
2024 Sep 10:386:q1961.
doi: 10.1136/bmj.q1961.
Authors
Susan Bewley
1
,
Kath Checkland
2
,
Paul Garner
3
,
Riittakerttu Kaltiala
4
5
,
Margaret McCartney
6
,
Carl Heneghan
7
,
Hannah Ryan
8
Affiliations
1
King's College London, London, UK.
2
University of Manchester, Manchester, UK.
3
Liverpool School of Tropical Medicine, Liverpool, UK.
4
Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.
5
Department of Adolescent Psychiatry, Tampere University Hospital, Tampere University, Tampere, Finland.
6
School of Medicine, University of St Andrews, St Andrews, UK.
7
University of Oxford, Oxford, UK.
8
Royal Liverpool University Hospital, Liverpool, UK.
PMID:
39255987
DOI:
10.1136/bmj.q1961
No abstract available
Publication types
Letter
MeSH terms
Biomedical Research / legislation & jurisprudence
Gonadotropin-Releasing Hormone*
Humans
United Kingdom
Substances
Gonadotropin-Releasing Hormone